243 related articles for article (PubMed ID: 22134627)
1. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV
Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
Jassal SV; Lok CE;
Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950
[TBL] [Abstract][Full Text] [Related]
3. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.
van Diepen AT; Tomlinson GA; Jassal SV
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1266-71. PubMed ID: 22745277
[TBL] [Abstract][Full Text] [Related]
4. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
[TBL] [Abstract][Full Text] [Related]
7. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
Mahaldar A; Weisz M; Kathuria P
Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
[TBL] [Abstract][Full Text] [Related]
10. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
[TBL] [Abstract][Full Text] [Related]
11. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
Davenport A;
J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
[TBL] [Abstract][Full Text] [Related]
13. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.
Chu KH; Choy WY; Cheung CC; Fung KS; Tang HL; Lee W; Cheuk A; Yim KF; Chan WH; Tong KL
Perit Dial Int; 2008; 28(5):505-8. PubMed ID: 18708544
[TBL] [Abstract][Full Text] [Related]
17. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.
Aykut S; Caner C; Ozkan G; Ali C; Tugba A; Zeynep G; Taner C
Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452
[TBL] [Abstract][Full Text] [Related]
18. Long-term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis.
Lopes K; Rocha A; Rodrigues A; Carvalho MJ; Cabrita A
Int J Artif Organs; 2013 Jul; 36(7):484-8. PubMed ID: 23661559
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
